Axelsen, A
A joint statement issued by the Brazilian Society of Endocrinology and Metabolism (SBEM), the Brazilian Diabetes Society (SBD), and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO), first released in February and reiterated later this year, called compounding a growing, concerning, and dangerous practice, lacking regulatory and scientific backing
No commercial sponsor will fund that for a compound it cannot exclusively monetise
Reviewing peptide before and after examples from others can help calibrate expectations
Key Companies in GLP-1 Analogues Market AstraZeneca Bristol-Myers Squibb Company D&D Pharmatech Eccogen Eli Lilly and Company Glenmark Pharmaceuticals Ltd
In addition, in prior studies, a wide variety of organic solvents, plant parts, and extraction procedures were employed to isolate different bioactive components